Geriatric Pharmacotherapy Case Series: Overactive Bladder

2020 ◽  
Vol 35 (5) ◽  
pp. 220-224
Author(s):  
Demetra Antimisiaris ◽  
Kristina Niehoff

GERIATRIC PHARMACOTHERAPY CASE SERIES<br/> This is the first in a series of clinical case studies developed by ASCP's Pharmacy Education and Research Committee. The series reviews approaches to managing complex problems when treating older people with concurrent chronic and acute conditions.<br/> This case study reviews the treatment of a patient with overactive bladder (OAB), a geriatric syndrome that is a prevalent and multifactorial health condition associated with substantial morbidity and poor outcomes in older people. This case illustrates a counterintuitive presentation of OAB, approaches to analyzing the case, and planning for treatment.

Author(s):  
Iván Sánchez-Martínez ◽  
Raül Vilar ◽  
Javier Irujo ◽  
Duna Ulsamer ◽  
Dolors Cano ◽  
...  

The purpose of this study was to carry out a literature review on the effectiveness of the validation method (VM) in job satisfaction and motivation of care professionals working with older people in nursing homes. The review was carried out in specialised databases: Scopus, PsychINFO, PubMed, Web of Science (WOS), Google Scholar, Scielo, and Cochrane Database of Systematic Reviews. 9046 results were obtained, out of which a total of 14 studies met the inclusion criteria: five quantitative, four qualitative, one single case series, two quasi-experimental and two mixed methods studies. The results of the analysed studies report that the VM can be an effective tool that facilitates communication and interaction in care, reducing levels of stress and job dissatisfaction among care professionals. The VM facilitates communication between professionals and older people with dementia, and improves the management of complex situations that may arise in care, directly influencing a reduction in work stress and increasing job satisfaction.


2007 ◽  
Vol 99 (3) ◽  
pp. 502-509 ◽  
Author(s):  
Adrian S. Wagg ◽  
Linda Cardozo ◽  
Christopher Chapple ◽  
Dirk De Ridder ◽  
Con Kelleher ◽  
...  

Author(s):  
Ahmad Amin ◽  
Seyed Parsa Eftekhar ◽  
Naghmeh Ziaei ◽  
Soudeh Roudbari ◽  
Pegah Salehi ◽  
...  

We described eleven patients positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The younger age and female gender seem to contribute to poor outcomes possibly. Furthermore, the left ventricle ejection fraction and pro-BNP improvement within the first week of treatment might indicate a good prognosis.


Author(s):  
Kainat Saleem ◽  
Azadeh Nasrazadani ◽  
Chaoyuan Kuang ◽  
Vanya Jaitly ◽  
Jonhan Ho ◽  
...  

We present four cases of intravascular large B-cell lymphoma (IVLBCL), a rare malignancy with poor outcomes. The exclusive presence of lymphoma cells in blood vessels leads to a heterogenous presentation and poor diagnostic yield with traditional initial diagnostic tools. Timely diagnosis and treatment can lead to improved outcomes.


2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Smita Bhagwan ◽  
Kogieleum Naidoo

We conducted a retrospective review of confirmed HIV-TB coinfected patients previously enrolled as part of the SAPiT study in Durban, South Africa. Patients with suspected meningitis were included in this case series. From 642 individuals, 14 episodes of meningitis in 10 patients were identified. For 8 patients, this episode of meningitis was the AIDS defining illness, with cryptococcus (9/14 episodes) and tuberculosis (3/14 episodes) as the commonest aetiological agents. The combination of headache and neck stiffness (78.6%) was the most frequent clinical presentation. Relapsing cryptococcal meningitis occurred in 3/7 patients. Mortality was 70% (7/10), with 4 deaths directly due to meningitis. In an HIV TB endemic region we identified cryptococcus followed by tuberculosis as the leading causes of meningitis. We highlight the occurrence of tuberculous meningitis in patients already receiving antituberculous therapy. The development of meningitis heralded poor outcomes, high mortality, and relapsing meningitis despite ART.


2017 ◽  
Vol 3 (4) ◽  
Author(s):  
Alessandra Anzuini ◽  
Francesca Massariello ◽  
Giuseppe Bellelli

Delirium is a geriatric syndrome, characterized by acutely altered mental status with inattention, fluctuating course and global cognitive dysfunction, which is associated with a significant burden in terms of negative outcomes and costs of care. Delirium is frequently undetected despite its prevalence and incidence are relevant. In this brief report, we report the state of the art in terms of prevention for both medical and surgical patients. A non-pharmacological approach seems to be the more promising method to prevent delirium and improve quality of care for people at risk.


2020 ◽  
Vol 20 (10) ◽  
pp. 892-898
Author(s):  
Masamitsu Sugie ◽  
Kazumasa Harada ◽  
Tetsuya Takahashi ◽  
Marina Nara ◽  
Hajime Fujimoto ◽  
...  

2019 ◽  
Vol 216 (1) ◽  
pp. 49-54 ◽  
Author(s):  
Antony Arthur ◽  
George M. Savva ◽  
Linda E. Barnes ◽  
Ayda Borjian-Boroojeny ◽  
Tom Dening ◽  
...  

BackgroundDepression is a leading cause of disability, with older people particularly susceptible to poor outcomes.AimsTo investigate whether the prevalence of depression and antidepressant use have changed across two decades in older people.MethodThe Cognitive Function and Ageing Studies (CFAS I and CFAS II) are two English population-based cohort studies of older people aged ≥65 years, with baseline measurements for each cohort conducted two decades apart (between 1990 and 1993 and between 2008 and 2011). Depression was assessed by the Geriatric Mental State examination and diagnosed with the Automated Geriatric Examination for Computer-Assisted Taxonomy algorithm.ResultsIn CFAS I, 7635 people aged ≥65 years were interviewed, of whom 1457 were diagnostically assessed. In CFAS II, 7762 people were interviewed and diagnostically assessed. Age-standardised depression prevalence in CFAS II was 6.8% (95% CI 6.3–7.5%), representing a non-significant decline from CFAS I (risk ratio 0.82, 95% CI 0.64–1.07, P = 0.14). At the time of CFAS II, 10.7% of the population (95% CI 10.0–11.5%) were taking antidepressant medication, more than twice that of CFAS I (risk ratio 2.79, 95% CI 1.96–3.97, P < 0.0001). Among care home residents, depression prevalence was unchanged, but the use of antidepressants increased from 7.4% (95% CI 3.8–13.8%) to 29.2% (95% CI 22.6–36.7%).ConclusionsA substantial increase in the proportion of the population reporting taking antidepressant medication is seen across two decades for people aged ≥65 years. However there was no evidence for a change in age-specific prevalence of depression.


Sign in / Sign up

Export Citation Format

Share Document